- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05291494
A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer Patients
August 28, 2022 updated by: Chunling Jiang, West China Hospital
A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer Patients: a Prospective Randomized Controlled Study
Patients who meet the enrollment criteria will be randomly assigned to the WeChat education group and the regular group.
In addition to the regular preoperative visits, the WeChat education group will also watch science videos through WeChat before the surgical procedures.
The regular group only received regular preoperative visits and education by ward nurses.
The main observation indicator is the incidence of preoperative anxiety defined as the scores of State Anxiety Inventory more than 40 points.
Study Overview
Status
Completed
Conditions
Detailed Description
Patients who meet the inclusion criteria will be randomly assigned to the WeChat online education group or the regular group.
Two researchers will conduct preoperative education, preoperative evaluation and postoperative follow-up respectively.The patients in WeChat group will be first assessed by a researcher on admission about anxiety and sleep (base on the State-Trait Anxiety Inventory (STAI) scale and the sleep quality scale (SQS)).
Once the assessment completed, the patients are required to follow the WeChat public platform to watch the education videos when they are free.
The content of the videos is jointly decided by the breast surgeon, anesthetists, and ward nurse including the overall prognosis, surgical approach, postoperative rehabilitation exercises, preparation for anesthesia, anesthesia approach and possible effects of anesthesia, which covers all aspects of surgery, anesthesia, and perioperative care.
The videos are presented in an easy-to-understand pattern to ensure participants of all ages and levels of education comfortably understand the content.
Participants can simply click on the video dialogue box in the public platform for playback and watch it unconditionally.Patients in regular group will be also assessed by the same researcher on admission for anxiety and sleep (base on State-Trait Anxiety Inventory (STAI) scale; sleep quality scale (SQS) scale).
Upon completion of the assessment, they received oral instruction from the ward nurse covering the same contents as above instead of the education video.
Study Type
Interventional
Enrollment (Actual)
392
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- West China Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- female patients scheduled for elective breast cancer resection;
- aged 18 to 80 years,;
- American Society of Anesthesiologists (ASA) physical status I-III.
Exclusion Criteria:
- patients diagnosed with primary breast cancer combined with malignant tumors of other organs (such as lung, kidney, intestine, etc.);
- patients with tumor recurrence after reoperation;
- patients failing to cooperate with the study for any reason, such as communication disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: WeChat group
The patients in this group will be first assessed by a researcher on admission about anxiety and sleep (base on the State-Trait Anxiety Inventory (STAI) scale and the sleep quality scale (SQS)).
Once the assessment completed, the patients are required to follow the WeChat public platform to watch the education videos when they are free.
The content of the videos covers all aspects of surgery, anesthesia, and perioperative care.
The videos are presented in an easy-to-understand pattern to ensure participants of all ages and levels of education comfortably understand the content.
|
In addition to the regular preoperative visits, the WeChat education group will watch science videos through WeChat before the surgical procedures.
|
|
Placebo Comparator: Regular group
Patients in this group were also assessed by the same researcher on admission for anxiety and sleep (base on State-Trait Anxiety Inventory (STAI) scale; sleep quality scale (SQS) scale).
Upon completion of the assessment, they received oral instruction from the ward nurse covering the same contents as above instead of the education video.
|
received oral instruction from the ward nurse covering the same contents as above instead of the education video.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the incidence of preoperative anxiety
Time Frame: The day before surgery
|
The primary outcome indicator is the incidence of preoperative anxiety, defined as a S-AI(The State Anxiety Inventory)score of >40.The total S-AI score ranges from 20 to 80, with higher scores indicating more severe anxiety.When S-AI score exceeds 40, a state of clinical anxiety is confirmed25,26.A S-AI score outstripping 44 strongly denotes severe anxiety.
|
The day before surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of severe anxiety (S-AI > 44) on 1day before and at 72 hours after surgery
Time Frame: The day before and at 72 hours after surgery
|
Subjects will be assessed for anxiety on 1day before and at 72 hours after surgery
|
The day before and at 72 hours after surgery
|
|
incidence of anxiety 72 hours after surgery
Time Frame: at 72 hours after surgery
|
Subjects will be assessed for anxiety on 1day before and at 72 hours after surgery
|
at 72 hours after surgery
|
|
NRS scores for pain at rest and during movement
Time Frame: at 24,48 , 72 hours after surgery
|
The pain is evaluated using numerical rating scale(NRS).
NRS scores range from 0 to 10 points, with 0 points representing no pain, 1-3 points representing mild pain, 4-6 points representing moderate pain, 7-9 points representing severe pain and 10 points representing the strongest pain.
|
at 24,48 , 72 hours after surgery
|
|
incidence of PONV within 24 hours after surgery
Time Frame: during the first 24 hours after surgery
|
the investigators considered it PONV if patients felt any nausea or had any vomiting
|
during the first 24 hours after surgery
|
|
subjective sleep score (Sleep Quality Score (SQS))
Time Frame: At 1 week after surgery
|
subjective sleep score(Sleep Quality Score (SQS)) at 1 week postoperatively.SQS is a self-assessment questionnaire with discrete visual analog scale (VAS).
The questionnaire asked the respondents to score the overall sleep quality of the 7-day recall period on a discrete VAS scale.
The respondents scored on the following five categories, with a score of 0 to 10:0 = bad, 1-3 = poor, 4-6 = fair, 7-9 = good and 10 = very good.
|
At 1 week after surgery
|
|
quality of life QoR-15 scores at 1 and 3 months postoperatively
Time Frame: at 1 and 3 months after surgery
|
The investigators use the 15-item quality of recovery score (QoR-15 questionnaire) to reveal the life quality.QoR-15 consists of 15 questionnaires to assess patients' postoperative recovery, each of which is based on the pain rating scale and constructs an 11-point numerical rating scale.
For positive items, 0 = never and 10 = always; For negative items, the score was reversed, and the final score was the sum of the 15 items, with the highest score being 150.
The higher the score, the better the postoperative recovery.
|
at 1 and 3 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2021
Primary Completion (Actual)
March 31, 2022
Study Completion (Actual)
March 31, 2022
Study Registration Dates
First Submitted
December 29, 2021
First Submitted That Met QC Criteria
March 18, 2022
First Posted (Actual)
March 22, 2022
Study Record Updates
Last Update Posted (Actual)
August 31, 2022
Last Update Submitted That Met QC Criteria
August 28, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-1138
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer Female
-
University of Kansas Medical CenterRecruitingBreast Cancer FemaleUnited States
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerGermany
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
Dalarna County Council, SwedenRecruitingBreast Cancer - FemaleSweden
-
Al-Quds UniversityNot yet recruitingThe Effect of Psychosocial Support on Improving Breast Cancer Patients Response to Medical TreatmentBreast Cancer - FemalePalestinian Territories
-
Izmir Biomedicine and Genome CenterDokuz Eylul University; Antalya Training and Research Hospital; Akdeniz University...Enrolling by invitationFemale Breast Cancer PatientsTurkey (Türkiye)
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
Clinical Trials on follow the WeChat public platform to watch the education videos
-
Hospices Civils de LyonNot yet recruiting
-
Xiang GuScience and Technology Department of Jiangsu Province; Yangzhou Municipal Health...UnknownChronic Heart FailureChina
-
Eskisehir Osmangazi UniversityCompletedEssential Hypertension | Cardiovascular Disease Risk | Motivational Interview | Healthy Lifestyle BehaviorTurkey
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Caregiver | Salivary Gland Squamous Cell Carcinoma | Malignant Head and Neck Neoplasm | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Stage... and other conditionsUnited States
-
Pontificia Universidad Catolica de ChileNot yet recruitingAnesthesia | Regional Anesthesia Success | Regional Anesthesia | Anesthesia , AnalgesiaChile
-
Castilla-La Mancha Health ServiceColegio Oficial de Terapeutas Ocupacionales de Castilla - La Mancha; Fundación... and other collaboratorsActive, not recruiting
-
Norwegian Institute of Public HealthUniversity of Oslo; Oslo University Hospital; Oslo MunicipalityActive, not recruitingHip Fractures | Fall Injury